| VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG and Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. Archives of Medical Science. Poland: Termedia Publishing House, 2020, vol. 16, No 5, p. 1239-1242. ISSN 1734-1922. Available from: https://dx.doi.org/10.5114/aoms.2020.97969. |
Other formats:
BibTeX
LaTeX
RIS
@article{1677999,
author = {Veselka, Josef and Faber, Lothar and Liebregts, Max and Cooper, Robert and Januska, Jaroslav and Krejčí, Jan and Dabrowski, Maciej and Hansen, Peter Riis and Seggewiss, Hubert and Horstkotte, Dieter and Hansvenclova, Eva and Bundgaard, Henning and ten Berg, Jurrien and Jensen, Morten Kvistholm},
article_location = {Poland},
article_number = {5},
doi = {http://dx.doi.org/10.5114/aoms.2020.97969},
keywords = {septal reduction therapy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy},
language = {eng},
issn = {1734-1922},
journal = {Archives of Medical Science},
title = {Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry},
url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/},
volume = {16},
year = {2020}
}
TY - JOUR
ID - 1677999
AU - Veselka, Josef - Faber, Lothar - Liebregts, Max - Cooper, Robert - Januska, Jaroslav - Krejčí, Jan - Dabrowski, Maciej - Hansen, Peter Riis - Seggewiss, Hubert - Horstkotte, Dieter - Hansvenclova, Eva - Bundgaard, Henning - ten Berg, Jurrien - Jensen, Morten Kvistholm
PY - 2020
TI - Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry
JF - Archives of Medical Science
VL - 16
IS - 5
SP - 1239-1242
EP - 1239-1242
PB - Termedia Publishing House
SN - 17341922
KW - septal reduction therapy
KW - alcohol septal ablation
KW - hypertrophic obstructive cardiomyopathy
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
N2 - Two-thirds of patients with hypertrophic cardiomyopathy (HCM) have a significant left ventricular outflow tract (LVOT) obstruction that may be treated with alcohol septal ablation (ASA) dependent on symptoms. However, some degree of obstruction may remain after ASA and if the patient remains symptomatic repeated septal reduction therapy (RSRT) may be indicated. The outcome of RSRT remains unknown. In this study, we sought to determine the long-term outcomes of patients treated with ASA or myectomy after previous ASA.
ER -
VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG and Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. \textit{Archives of Medical Science}. Poland: Termedia Publishing House, 2020, vol.~16, No~5, p.~1239-1242. ISSN~1734-1922. Available from: https://dx.doi.org/10.5114/aoms.2020.97969.
|
